These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29378766)

  • 1. Response by Merghani et al to Letters Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Merghani A; Maestrini V; Rosmini S; Cox AT; Dhutia H; Bastiaenan R; David S; Yeo TJ; Narain R; Malhotra A; Papadakis M; Wilson MG; Tome M; AlFakih K; Moon JC; Sharma S
    Circulation; 2018 Jan; 137(5):541-542. PubMed ID: 29378766
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Harrell et al Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Harrell TE; Stoebner RA; Boswell GE
    Circulation; 2018 Jan; 137(5):537-538. PubMed ID: 29378764
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile.
    Merghani A; Maestrini V; Rosmini S; Cox AT; Dhutia H; Bastiaenan R; David S; Yeo TJ; Narain R; Malhotra A; Papadakis M; Wilson MG; Tome M; AlFakih K; Moon JC; Sharma S
    Circulation; 2017 Jul; 136(2):126-137. PubMed ID: 28465287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter by Schmermund Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Schmermund A
    Circulation; 2018 Jan; 137(5):539-540. PubMed ID: 29378765
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter by Jin-shan and Xue-bin Regarding Article, "Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile".
    Jin-Shan H; Xue-Bin L
    Circulation; 2018 Jan; 137(5):536. PubMed ID: 29378763
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary Atherosclerosis in Masters Athletes: Mechanisms and Implications for Cardiovascular Disease Risk.
    Fernandez AB; Chaudhry W; Thompson PD
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(12):87. PubMed ID: 31823073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical coronary artery disease in veteran athletes: is a new preparticipation methodology required?
    Dores H; de Araújo Gonçalves P; Monge J; Costa R; Tátá L; Malhotra A; Sharma S; Cardim N; Neuparth N
    Br J Sports Med; 2020 Mar; 54(6):349-353. PubMed ID: 30413429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Lifelong Exercise Volume and Coronary Atherosclerosis in Athletes.
    Aengevaeren VL; Mosterd A; Braber TL; Prakken NHJ; Doevendans PA; Grobbee DE; Thompson PD; Eijsvogels TMH; Velthuis BK
    Circulation; 2017 Jul; 136(2):138-148. PubMed ID: 28450347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin to Prevent Sudden Cardiac Death in Athletes with High Coronary Artery Calcium Scores.
    Siegel AJ; Noakes TD
    Am J Med; 2019 Feb; 132(2):138-141. PubMed ID: 30296406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary atherosclerosis and cardiovascular risk in masters male marathon runners. Rationale and design of the "marathon study".
    Möhlenkamp S; Schmermund A; Kröger K; Kerkhoff G; Bröcker-Preuss M; Adams V; Hensel M; Kiefer D; Lehmann N; Moebus S; Leineweber K; Elsenbruch S; Barkhausen J; Halle M; Hambrecht R; Siegrist J; Mann K; Budde T; Jöckel KH; Erbel R
    Herz; 2006 Sep; 31(6):575-85. PubMed ID: 17036189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study.
    Fernández-Friera L; Peñalvo JL; Fernández-Ortiz A; Ibañez B; López-Melgar B; Laclaustra M; Oliva B; Mocoroa A; Mendiguren J; Martínez de Vega V; García L; Molina J; Sánchez-González J; Guzmán G; Alonso-Farto JC; Guallar E; Civeira F; Sillesen H; Pocock S; Ordovás JM; Sanz G; Jiménez-Borreguero LJ; Fuster V
    Circulation; 2015 Jun; 131(24):2104-13. PubMed ID: 25882487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical predictors of atherosclerotic coronary artery disease in asymptomatic patients undergoing coronary multidetector computed tomography.
    Bachar GN; Atar E; Fuchs S; Dror D; Kornowski R
    Coron Artery Dis; 2007 Aug; 18(5):353-60. PubMed ID: 17627184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of exercise to coronary artery disease extent, severity and plaque type: A coronary computed tomography angiography study.
    Feuchtner G; Langer C; Barbieri F; Beyer C; Dichtl W; Bonaros N; Cartes-Zumelzu F; Klauser A; Schachner T; Friedrich G; Plank F; Senoner T
    J Cardiovasc Comput Tomogr; 2019; 13(3):34-40. PubMed ID: 30837117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study.
    Laclaustra M; Casasnovas JA; Fernández-Ortiz A; Fuster V; León-Latre M; Jiménez-Borreguero LJ; Pocovi M; Hurtado-Roca Y; Ordovas JM; Jarauta E; Guallar E; Ibañez B; Civeira F
    J Am Coll Cardiol; 2016 Mar; 67(11):1263-74. PubMed ID: 26988945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponins: Potential biomarkers for the detection of subclinical coronary artery disease in athletes participating in endurance sports.
    Nie J
    Eur J Prev Cardiol; 2018 Jan; 25(1):110-111. PubMed ID: 28569552
    [No Abstract]   [Full Text] [Related]  

  • 16. Sleep duration and subclinical atherosclerosis: The Aragon Workers' Health Study.
    Blasco-Colmenares E; Moreno-Franco B; Latre ML; Mur-Vispe E; Pocovi M; Jarauta E; Civeira F; Laclaustra M; Casasnovas JA; Guallar E
    Atherosclerosis; 2018 Jul; 274():35-40. PubMed ID: 29751282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Risk and Disease Among Masters Endurance Athletes: Insights from the Boston MASTER (Masters Athletes Survey To Evaluate Risk) Initiative.
    Shapero K; Deluca J; Contursi M; Wasfy M; Weiner RB; Lewis GD; Hutter A; Baggish AL
    Sports Med Open; 2016 Dec; 2():29. PubMed ID: 27547715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid and peripheral atherosclerosis in male marathon runners.
    Kröger K; Lehmann N; Rappaport L; Perrey M; Sorokin A; Budde T; Heusch G; Jöckel KH; Thompson PD; Erbel R; Möhlenkamp S
    Med Sci Sports Exerc; 2011 Jul; 43(7):1142-7. PubMed ID: 21200345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Subclinical Coronary Artery Disease in Middle-Aged, Male Marathon Runners Detected by Cardiac CT.
    Tsiflikas I; Thomas C; Fallmann C; Schabel C; Mangold S; Ketelsen D; Claussen CD; Axmann D; Schroeder S; Burgstahler C
    Rofo; 2015 Jul; 187(7):561-8. PubMed ID: 25831468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery disease in masters-level athletes.
    Whiteson JH; Bartels MN; Kim H; Alba AS
    Arch Phys Med Rehabil; 2006 Mar; 87(3 Suppl 1):S79-81; quiz S82-3. PubMed ID: 16500195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.